Heart Disease Clinical Trials in Philadelphia

Showing 81-100 of 263 trials

Developing Oral LT3 Therapy for Heart Failure - HFrEF

NCT04112316

Investigation of the safety, feasibility, and preliminary efficacy of thyroid hormone therapy with Liothyronine (LT3) in individuals with heart failure with reduced ejection fraction (HFrEF) and low triiodothyronine (T3) syndrome by conducting a randomized, double-blind, placebo-controlled cross-over study with a two-week washout period between treatments.

Heart Failure With Reduced Ejection Fraction (HFrEF)Low T3 Syndrome

University of Pennsylvania28 participantsStarted Feb 2020

Philadelphia, Pennsylvania, United States

COMPLETEDPHASE3< 1 mile

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

NCT00826280

Observe whether the administration of caffeine prior to regadenoson will affect the interpretation of test results in subjects with coronary artery disease (CAD) undergoing SPECT MPI

Coronary Artery Disease (CAD)

Astellas Pharma Inc347 participantsStarted Mar 2009

Birmingham, Alabama, United States • Huntsville, Alabama, United States • La Mesa, California, United States +22 more locations

Developing Oral LT3 Therapy for Heart Failure - HFrEF

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Heart Disease Trials in Other Cities

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

Twitter and Diabetes

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

Default Bulk Ordering and Text Messaging to Enhance Outreach for Lipid Screening (Missing Lipids)

A Study to Evaluate Lung Ultrasound as a Method to Measure Changes in Extravascular Lung Water Induced by Positional Changes (LUPE)

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

Benefits of Microcor in Ambulatory Decompensated Heart Failure

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

REmodeling the Left Ventricle With Atrial Modulated Pacing

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon

ELUCIDATE FFRct Study

Rivet PVS Therapy in Group 2 PH-HFpEF

Study of Verinurad in Heart Failure With Preserved Ejection Fraction

Cardionomic STOP-ADHF Study

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Other Conditions in Philadelphia